25 May 2013
Keywords: eisai, delay, e2007, filing, until, fiscal, japanese
Article | 05 November 2007
Japanese drugmaker Eisai is to delay filing its developmental alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor antagonist E2007 (perampanel) until ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.